- Home
- AGIO vs UPWK Comparison
AGIO vs UPWK Comparison
Compare AGIO & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- UPWK
- Stock Information
- Founded
- AGIO 2007
- UPWK 2013
- Country
- AGIO United States
- UPWK United States
- Employees
- AGIO N/A
- UPWK N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- UPWK EDP Services
- Sector
- AGIO Health Care
- UPWK Technology
- Exchange
- AGIO Nasdaq
- UPWK Nasdaq
- Market Cap
- AGIO 2.4B
- UPWK 2.0B
- IPO Year
- AGIO 2013
- UPWK 2018
- Fundamental
- Price
- AGIO $40.72
- UPWK $16.93
- Analyst Decision
- AGIO Strong Buy
- UPWK Buy
- Analyst Count
- AGIO 5
- UPWK 14
- Target Price
- AGIO $57.25
- UPWK $19.46
- AVG Volume (30 Days)
- AGIO 577.5K
- UPWK 3.4M
- Earning Date
- AGIO 10-30-2025
- UPWK 11-05-2025
- Dividend Yield
- AGIO N/A
- UPWK N/A
- EPS Growth
- AGIO N/A
- UPWK 220.06
- EPS
- AGIO 11.13
- UPWK 1.72
- Revenue
- AGIO $40,875,000.00
- UPWK $772,904,000.00
- Revenue This Year
- AGIO $23.76
- UPWK $2.44
- Revenue Next Year
- AGIO $148.23
- UPWK $5.34
- P/E Ratio
- AGIO $3.67
- UPWK $9.90
- Revenue Growth
- AGIO 30.57
- UPWK 3.92
- 52 Week Low
- AGIO $23.42
- UPWK $9.93
- 52 Week High
- AGIO $62.58
- UPWK $20.54
- Technical
- Relative Strength Index (RSI)
- AGIO 63.66
- UPWK 46.85
- Support Level
- AGIO $39.32
- UPWK $18.86
- Resistance Level
- AGIO $41.42
- UPWK $18.43
- Average True Range (ATR)
- AGIO 1.34
- UPWK 0.94
- MACD
- AGIO 0.34
- UPWK -0.39
- Stochastic Oscillator
- AGIO 87.58
- UPWK 10.27
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.